Chuangyuan Bio is a CDMO company with top chemical total synthesis technology, focusing on the research and development services of small molecule innovative drugs and generic drugs in various cancer fields. It has profound technical reserves in the total synthesis and transformation of anticancer drug molecules such as paclitaxel, colchicine, trabectedin, and fulvestrant, especially in the total synthesis and transformation of various natural anticancer drug molecules, which can provide the most innovative drug companies with the most advanced technology. Excellent synthesis and production solutions to provide customers with integrated services